Genetic research offers AMD hope

Researchers have examined whether a new treatment for AMD could be developed

Funding for research into the genetic causes of age-related macular degeneration (AMD) has been provided by sight loss charity Fight for Sight with the support of TP ICAP.

Researchers explained that the study would investigate which chromosomes cause AMD with the intention of identifying a possible new treatment for the disease.

Dr Felix Grassmann, the study’s leader at the University of Aberdeen, explained: ‘There is evidence that the risk of developing AMD is linked to a deterioration of chromosomes in immune cells found in the blood.’

The study’s leaders planned to examine the chromosomes of these immune cells in people with macular degeneration to determine whether there was a pattern that could be used to identify those most at risk of vision loss.

Register now to continue reading

Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.


Already have an account? Sign in here